Data from Phase 1b dose escalation and expansion trial (n=69) shows a favorable safety profile, with manageable adverse events consistent with ...
Important disclaimers about supplement use, medical guidance, and consumer protection This comprehensive overview is crafted to assist readers in making a well-informed decision about whether this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results